Program areas at Karmanos Cancer Center
Inpatient: health care delivery & management: Barbara Ann Karmanos Cancer Hospital is dedicated to the delivery of Cancer care services, the treatment and care of Cancer patients and the prevention of Cancer. Additionally, Karmanos promotes, encourages, aids and performs scientific investigations and research addressing the cause, treatment and prevention of Cancer. Essential Cancer medical services are provided to the community. From october 2022 to september 2023, Karmanos had 20,656 patient days and 2,188 discharges for an average length of stay of 9.44 days. In addition, there were 245 bone marrow transplant cases, 801 inpatient surgical cases, and 6,408 inpatient imaging cases.
The Barbara Ann Karmanos Cancer Hospital promotes aids and performs scientific investigations and research addressing the cause, treatments and prevention of Cancer. For the period october 2022 to september 30, 2023, kcc had 3,635 phase 1 infusion patient visits, 265 active clinical drug trials; 253 patients willing to participate in clinical programs, and 425 eligible and registered participants.
Ambulatory services: the Barbara Ann Karmanos Cancer Hospital provided medical services to Cancer patients including radiation oncology, chemotherapy, bone marrow transplant, mammography and hematology consultative, diagnostic and treatment services. Essential Cancer and medical services are provided to the community. From october 2022 to september 2023, the following outpatient statistics were reported: clinical visits of 60,794; infusion patients of 22,896; imaging procedures of 42,996; pheresis patients totalled 633; inpatient and outpatient radiation oncology procedures of 27,140 and outpatient surgical cases of 1,440.